FDA ‘Data Dashboard’ Offers Insight Into Industry Trends
This article was originally published in The Silver Sheet
The new online tool will help assist in analyzing cross-agency inspection, warning letter, enforcement and recall data, the agency says. The dashboard is part of FDA’s ongoing Transparency Initiative.
You may also be interested in...
AdvaMed Accell executive director Ashley Wittorf spoke in support of a proposed US House bill that would give financial help to small companies making products to address COVID-19.
Risdiplam’s efficacy across two clinical trials and oral dosing made it a credible threat before its US FDA approval, but its weight-based pricing falls below Biogen’s Spinraza and Novartis’s Zolgensma.
A pilot that used RFID tags with 2D barcodes was touted as more effective than using 2D barcodes alone in tracking drugs through the supply chain.